| Autor: |
Roesel, Maximilian J., Nersesian, Gaik, Neuber, Sebastian, Thau, Henriette, von Gudenberg, Rosalie Wolff, Lanmueller, Pia, Hennig, Felix, Falk, Volkmar, Potapov, Evgenij, Knosalla, Christoph, Iske, Jasper |
| Zdroj: |
Reviews in Cardiovascular Medicine; 2024, Vol. 25 Issue 5, p1-11, 11p |
| Abstrakt: |
Heart failure (HF) is a common disease associated with high morbidity and mortality rates despite advanced pharmacological therapies. Heart transplantation remains the gold standard therapy for end-stage heart failure; however, its application is curtailed by the persistent shortage of donor organs. Over the past two decades, mechanical circulatory support, notably Left Ventricular Assist Devices (LVADs), have been established as an option for patients waiting for a donor organ. This comprehensive review focuses on elucidating the benefits and barriers associated with this application. We provide an overview of landmark clinical trials that have evaluated the use of LVADs as a bridge to transplantation therapy, with a particular focus on post-transplant outcomes. We discuss the benefits of stabilizing patients with these systems, weighing associated complications and limitations. Further technical advancements and research on optimal implantation timing are critical to ultimately improve outcomes and securing quality of life. In a world where the availability of donor organs remains constrained, LVADs are an increasingly important piece of patient care, bridging the critical gap to transplantation in advanced heart failure management. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
